Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUGGC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | FRMD6 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | B4GALNT4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | USH2A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | RLN3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | NQO1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | POU4F3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | RP11-345F18.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | PAN3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | LEF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |